Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTAW) Total Liabilities (2019 - 2025)

Historic Total Liabilities for Strata Critical Medical (SRTAW) over the last 7 years, with Q3 2025 value amounting to $52.1 million.

  • Strata Critical Medical's Total Liabilities rose 532.3% to $52.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.1 million, marking a year-over-year increase of 532.3%. This contributed to the annual value of $34.7 million for FY2024, which is 4271.41% down from last year.
  • According to the latest figures from Q3 2025, Strata Critical Medical's Total Liabilities is $52.1 million, which was up 532.3% from $34.8 million recorded in Q2 2025.
  • Over the past 5 years, Strata Critical Medical's Total Liabilities peaked at $60.6 million during Q4 2023, and registered a low of $30.8 million during Q1 2025.
  • Over the past 5 years, Strata Critical Medical's median Total Liabilities value was $49.4 million (recorded in 2024), while the average stood at $47.0 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first soared by 68620.95% in 2021, then crashed by 4271.41% in 2024.
  • Quarter analysis of 5 years shows Strata Critical Medical's Total Liabilities stood at $44.5 million in 2021, then increased by 13.53% to $50.5 million in 2022, then rose by 19.99% to $60.6 million in 2023, then plummeted by 42.71% to $34.7 million in 2024, then soared by 49.92% to $52.1 million in 2025.
  • Its last three reported values are $52.1 million in Q3 2025, $34.8 million for Q2 2025, and $30.8 million during Q1 2025.